Metabolic
Setmelanotide
Imcivree / RM-493
- Peptide length
- 8 amino acids
Cyclic peptide
Research contextDefined therapeutic evidence
Read the linked studies for their methods and limitations.
An MC4-receptor agonist used for specific causes of obesity. The 2026 FDA label includes acquired hypothalamic obesity alongside defined genetic conditions.
- Family
- Melanocortin receptor agonist
- Research frame
- Melanocortin 4 receptor
- Molecular format
- Cyclic peptide
Read the evidence
Eligibility depends on the exact labeled condition and age group. This is not evidence for general obesity treatment.
Resolve the identity
Distinguish setmelanotide from other melanocortin agonists; shared receptor language does not imply the same clinical indication.